Identification of such biomarkers has potential impact on the screening of new bovine TB vaccines, allowing for initial gating criteria to be used when analysing vaccine-induced immunity that prioritises vaccines driving IL-17A and IL-22 responses for further evaluation in more costly vaccine challenge experiments. The gene discussed is IL17A; the disease is tuberculosis.